• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因血友病筛查项目鉴定出 2 种新型变异,包括一种新型变异(c.5816-2A>G),导致因子 8 基因的致病性变异。

Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene.

机构信息

Department of Pathology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Department of Clinical Pathology/Hematology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.

出版信息

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231182410. doi: 10.1177/10760296231182410.

DOI:10.1177/10760296231182410
PMID:37525882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395182/
Abstract

Establishing a national screening program for hemophilia patients is highly encouraged by the World Health Organization and the World Federation of Hemophilia. Hence, this study aimed to analyze the variant spectrum of and genes in Arab hemophilia patients. Molecular genetic and sequencing studies were performed on a cohort of 135 Saudi hemophilia patients. Out of all screened hemophilia patients (97 hemophilia A and 39 hemophilia B), 15 (11.1%) were positive for inversion 22 and 4 (3%) for inversion 1. Out of a total of 32 (23.7%) substitution/deletion mutations, 2 novel variants were identified: a novel splice acceptor site missense mutation (c.5816-2A > G) causing a pathogenic variant of the gene and another splicing site point mutation in intron/exon 23 (g.164496G > A). The frequent variants were (c.409A > C, p.T137P) in exon 4, (c.760A > G) in exon 6, and (c.1835G > C, p.R612P) in exon 12, while the frequent variants were (c.580A > G) in exon 6 and (c.880C > T) in exon 8. These study data will enrich the spectrum of the genetic databases in the Arab population that could be applied in the future for national genetic counseling.

摘要

世界卫生组织和世界血友病联盟强烈鼓励建立血友病患者国家筛查计划。因此,本研究旨在分析阿拉伯血友病患者的 和 基因变异谱。对 135 名沙特血友病患者进行了分子遗传学和测序研究。在所筛选的所有血友病患者(97 例血友病 A 和 39 例血友病 B)中,有 15 例(11.1%)存在 22 号倒位,4 例(3%)存在 1 号倒位。在总共 32 例(23.7%)取代/缺失突变中,发现了 2 种新的变异:一种新的剪接受体位点错义突变(c.5816-2A > G)导致 基因的致病性变异,以及另一种在内含子/外显子 23 中的剪接位点点突变(g.164496G > A)。常见的 变异包括外显子 4 中的 c.409A > C,p.T137P,外显子 6 中的 c.760A > G,以及外显子 12 中的 c.1835G > C,p.R612P,而常见的 变异包括外显子 6 中的 c.580A > G 和外显子 8 中的 c.880C > T。这些研究数据将丰富阿拉伯人群遗传数据库的谱,未来可应用于国家遗传咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f3/10395182/2ead782f401e/10.1177_10760296231182410-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f3/10395182/2ead782f401e/10.1177_10760296231182410-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f3/10395182/2ead782f401e/10.1177_10760296231182410-fig1.jpg

相似文献

1
Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene.基因血友病筛查项目鉴定出 2 种新型变异,包括一种新型变异(c.5816-2A>G),导致因子 8 基因的致病性变异。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231182410. doi: 10.1177/10760296231182410.
2
Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.根据 ACMG/AMP 指南分类的来自 PedNet 血友病登记处的新型 F8 和 F9 基因突变。
Hum Mutat. 2020 Dec;41(12):2058-2072. doi: 10.1002/humu.24117. Epub 2020 Oct 14.
3
Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.利用靶向高通量测序技术鉴定血友病家族中F8和F9基因的突变
Haemophilia. 2016 Sep;22(5):e427-34. doi: 10.1111/hae.12924. Epub 2016 Jun 13.
4
The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.加拿大“血友病基因突变检测国家项目”数据库:十年回顾。
Am J Hematol. 2013 Dec;88(12):1030-4. doi: 10.1002/ajh.23557. Epub 2013 Sep 9.
5
Recurrent F8 and F9 gene variants result from a founder effect in two large French haemophilia cohorts.重复的 F8 和 F9 基因突变源于两个大型法国血友病队列的一个创始人效应。
Haemophilia. 2018 Jul;24(4):e213-e221. doi: 10.1111/hae.13480. Epub 2018 Apr 14.
6
First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations.首例突尼斯血友病 A 患者的分子诊断报告:8 种新致病突变的鉴定。
Diagn Pathol. 2012 Aug 10;7:93. doi: 10.1186/1746-1596-7-93.
7
8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations.270 例血友病 A 患者 8 个基因的突变谱:36 个新突变的鉴定。
Turk J Haematol. 2020 Aug 28;37(3):145-153. doi: 10.4274/tjh.galenos.2020.2019.0262. Epub 2020 Feb 6.
8
Clustered missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity.聚集性错义突变通过联合改变剪接和蛋白质生物合成及活性导致血友病 A。
Haematologica. 2018 Feb;103(2):344-350. doi: 10.3324/haematol.2017.178327. Epub 2017 Nov 23.
9
Molecular genotyping of hemophilia A in Saudi Arabia: report of 2 novel mutations.沙特阿拉伯血友病A的分子基因分型:2种新突变的报告。
Blood Coagul Fibrinolysis. 2009 Sep;20(6):415-8. doi: 10.1097/MBC.0b013e328329e456.
10
Sequencing of the factor 8(F8) coding regions in 10 Turkish hemophilia A patients reveals three novel pathological mutations, and one rediagnosis of von Willebrand's disease type 2N.对10名土耳其甲型血友病患者的凝血因子8(F8)编码区进行测序,发现了三种新的病理性突变,并对一名2N型血管性血友病患者进行了重新诊断。
Haemophilia. 2006 Jul;12(4):398-400. doi: 10.1111/j.1365-2516.2006.01302.x.

引用本文的文献

1
Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf Region.基于共识的海湾地区甲型血友病管理专家建议。
Acta Haematol. 2025;148(1):91-104. doi: 10.1159/000538400. Epub 2024 Apr 2.

本文引用的文献

1
A Novel Deletion Mutation of the F8 Gene for Hemophilia A.一种新型的甲型血友病F8基因突变。
Diagnostics (Basel). 2022 Nov 21;12(11):2876. doi: 10.3390/diagnostics12112876.
2
Defining the molecular pathology and consequent phenotypes in Egyptian HB patients.明确埃及乙肝患者的分子病理学及相应表型。
J Genet Eng Biotechnol. 2021 May 17;19(1):75. doi: 10.1186/s43141-021-00165-8.
3
Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China.在中国,对 485 个血友病 A 家系 F8 基因的突变分析及产前诊断。
Haemophilia. 2021 Jan;27(1):e88-e92. doi: 10.1111/hae.14206. Epub 2020 Nov 27.
4
The Human Gene Mutation Database (HGMD): optimizing its use in a clinical diagnostic or research setting.人类基因突变数据库(HGMD):优化其在临床诊断或研究环境中的使用。
Hum Genet. 2020 Oct;139(10):1197-1207. doi: 10.1007/s00439-020-02199-3. Epub 2020 Jun 28.
5
The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers.欧洲血友病和相关疾病协会(EAHAD)凝血因子变异数据库:为止血临床医生和研究人员提供的重要资源。
Haemophilia. 2020 Mar;26(2):306-313. doi: 10.1111/hae.13947. Epub 2020 Mar 13.
6
8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations.270 例血友病 A 患者 8 个基因的突变谱:36 个新突变的鉴定。
Turk J Haematol. 2020 Aug 28;37(3):145-153. doi: 10.4274/tjh.galenos.2020.2019.0262. Epub 2020 Feb 6.
7
Hemophilia A and B: molecular and clinical similarities and differences.甲型和乙型血友病:分子层面与临床的异同
Haematologica. 2019 Sep;104(9):1702-1709. doi: 10.3324/haematol.2019.221093. Epub 2019 Aug 8.
8
Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.基因型、表型和全基因组序列:来自“我的生活,我们的未来”血友病项目的方法。
Haemophilia. 2018 May;24 Suppl 6(Suppl 6):87-94. doi: 10.1111/hae.13506.
9
Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies.血友病患者中凝血因子 VIII 和凝血因子 IX 基因的分子分析:新突变的鉴定及分子动力学研究
J Clin Med Res. 2017 Apr;9(4):317-331. doi: 10.14740/jocmr2876w. Epub 2017 Feb 21.
10
The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.沙特血友病患者中凝血因子VIII和IX抑制剂的患病率:沙特全国血友病筛查项目的结果。
Medicine (Baltimore). 2017 Jan;96(2):e5456. doi: 10.1097/MD.0000000000005456.